{"title":"先天性梅毒的治疗。","authors":"J W Budell","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Although penicillin remains the drug of choice for congenital syphilis, the optimal regimen has not been established. The published clinical trials were completed before the development of repository preparations such as benzathine penicillin. Consequently, current therapy must be derived from available clinical and pharmacologic data.</p>","PeriodicalId":76030,"journal":{"name":"Journal of the American Venereal Disease Association","volume":"3 2 Pt 2","pages":"168-71"},"PeriodicalIF":0.0000,"publicationDate":"1976-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of congenital syphilis.\",\"authors\":\"J W Budell\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Although penicillin remains the drug of choice for congenital syphilis, the optimal regimen has not been established. The published clinical trials were completed before the development of repository preparations such as benzathine penicillin. Consequently, current therapy must be derived from available clinical and pharmacologic data.</p>\",\"PeriodicalId\":76030,\"journal\":{\"name\":\"Journal of the American Venereal Disease Association\",\"volume\":\"3 2 Pt 2\",\"pages\":\"168-71\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1976-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Venereal Disease Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Venereal Disease Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Although penicillin remains the drug of choice for congenital syphilis, the optimal regimen has not been established. The published clinical trials were completed before the development of repository preparations such as benzathine penicillin. Consequently, current therapy must be derived from available clinical and pharmacologic data.